A researcher in Japan has raised a seasonally timely question: what if Santa Claus had a communicable disease as he made his rounds (Furuse Y. Med J Aust 2019;211:523-524)?
Latest News
Future look: Drug approvals pending for 2020
December 5, 2019Three drugs for use in neurology or psychiatry have filed with Health Canada and are expected to be approved in 2020. All have received FDA approval in the U.S. Here is a summary of what is waiting in the wings. Read More
Proton pump inhibitors linked to neurological conditions
November 29, 2019A new analysis of the FDA adverse events database (FAERS) has reported that use of proton pump inhibitors (e.g. omeprazole, rabeprazole, lansoprazole, pantoprazole) may be associated with a risk of neurological conditions, including hearing and visual impairment, memory loss, neuropathy and migraine (Sci Rep 2019;9:17280). Read More
Progression independent of relapses (PIRA) in MS
November 21, 2019A new term in MS research that has emerged in recent years is PIRA, or progression independent of relapse activity. It purports to quantify the proportion of disability worsening due to non-inflammatory neurodegenerative processes. However, the new metric has its shortcomings and the methodology used to quantify PIRA has varied since the concept first appeared in 2017. Read More